MedCity News

5 Healthcare CEOs React to Dr. Oz’s CMS Appointment

Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase.

By Marissa Plescia

BioPharma, Pharma

Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

Kura Oncology already had a broad development plan for ziftomenib in leukemias, but the agreement with Kyowa Kirin provides the cash to execute it and a partner to commercialize the drug globally. Ziftomenib is in the same class of medicines as Syndax Pharmaceuticals’ Revuforj, which won FDA approval last week.

By Frank Vinluan

MedCity Influencers

Strategies to Reduce Diagnostic Errors in Patient Care Settings

Reducing diagnostic error is a significant part of healthcare organizations’ efforts to improve patient outcomes. By using data to recognize vulnerabilities in the diagnostic process, empowering their diagnostic teams and fostering an environment where every team player understands their vital role organizations can proactively correct the potential root causes of diagnostic errors.

By Dana Siegal

Latest News

MedCity Influencers

Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care

New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems.

By Dr. Padmashree “Champa” Chaudhury Woodham

Hospitals, Devices & Diagnostics Health Tech,

Orion Innovations’ Light-Up Infusion Device Helps Both Patients and Nurses, Research Shows

A Utah-based startup named Orion Innovations released two studies this month demonstrating its product’s efficacy. The device attaches to hospital IV lines and uses a light to assist nurses with the identification and tracing of medication infusion lines, with the goal of reducing errors.

By Katie Adams

BioPharma, Startups

Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D

Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry.

By Frank Vinluan

Consumer / Employer

World Class Health Snags $8M To Expand Global Centers of Excellence Network

World Class Health's $8 million in seed funding was led by AlleyCorp. The company serves self-funded employers and offers access to a global centers of excellence network.

By Marissa Plescia

MedCity Influencers

Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum

Ensuring that family caregivers, and hospice providers all get the support that they need is more than just about ensuring that a patient receives end-of-life care with the dignity and support they deserve.

By Cara McCarty Abbott

The Funding Model for Cancer Innovation is Broken — We Can Fix It

Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.

By Eve McDavid - CEO of Mission-Driven Tech

MedCity Influencers

Polypharmacy is a Health Killer: Personalized Medication Management is the Answer

We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

By Steve Goldberg

Exclusive

Heard at HLTH 2024: Insights from Innovative Healthcare Executives

Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.

By MedCity News

Health Tech, Policy

Telehealth Advocates Praise DEA’s 3rd Extension of Telemedicine Flexibilities, but Call for Further Action

The DEA recently announced the third extension of Covid-19 flexibilities for the virtual prescribing of controlled substances. Telehealth advocates applaud this move but remain hopeful for a more permanent solution in the future.

By Marissa Plescia

Startups Health Tech,

Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding

The Silicon Valley startup formerly known as Ciitizen relaunched as Citizen Health. The company seeks to empower patients with access to their complete health history — and it’s starting off by focusing on patients with rare diseases.

By Katie Adams

BioPharma, Pharma

Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda

Merck said topline Phase 3 results show an injectable version of Keytruda met the main goal of non-inferiority compared to the intravenously infused formulation that is the pharma giant’s top-selling product. Injectable Keytruda could help Merck compete against coming competition from biosimilars.

By Frank Vinluan

MedCity Influencers

The Role of Clinical Collaboration Platforms in Enhancing Sepsis Care Workflows

While clinical collaboration platforms have already made a significant impact, there is still much work to be done to ensure that every hospital has the tools and protocols in place to respond to sepsis with the urgency it demands.

By Ashley Franks

MedCity Influencers

Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025?

What concrete strategies should employers pursue to control rising costs while ensuring the best member experience and clinical outcomes?

By Stanley Crittenden

Hospitals, Health Tech Providers,

How Emory’s New Partnership Seeks to Scale Value-Based Care Across Georgia

Emory Healthcare in Atlanta announced a partnership with Guidehealth, value-based care enablement startup. The collaboration is designed to help primary care reach more than 350,000 patients across Georgia.

By Katie Adams

Health Tech, Consumer / Employer

Evvy Introduces Treatments for Common Vaginal Symptoms

Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company's website, with prices ranging from $35 to $59.

By Marissa Plescia

BioPharma, Pharma

Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval

Approval of Syndax’s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson & Johnson subsidiary Janssen.

By Frank Vinluan